Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,935 public trials 1,510 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

NCT05456685

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center /ID# 268906 Tucson, Arizona, United States
  • Women'S Cancer Research Network - Cogi /ID# 268912 Fresno, California, United States
  • Providence - St. Jude Medical /ID# 268911 Fullerton, California, United States
  • Moores Cancer Center /ID# 268888 La Jolla, California, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

NCT02817633

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +26 more
Locations
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details
Active, Not Recruiting

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NCT03383094

Conditions
Cancer, Cancer of Head and Neck, Cancer, Advanced, +35 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer Center & Research Facility Tampa, Florida, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

NCT04365374

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +10 more
Locations
  • HonorHeath Scottsdale Osborn Medical Center Phoenix, Arizona, United States
  • University of Arkansas Medical Center Little Rock, Arkansas, United States
  • Ascension St. Vincent's- Riverside Jacksonville, Florida, United States
  • Baptist MD Anderson Cancer Center- Jacksonville Jacksonville, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Conditions
Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
Locations
  • Local Institution - 001-826 Birmingham, Alabama, United States
  • Local Institution - 001-965 Anchorage, Alaska, United States
  • Local Institution - 001-821 Phoenix, Arizona, United States
  • Local Institution - 001-873-A Tucson, Arizona, United States
View all 222 locations
View Trial Details

Related conditions